Global Helminthic Infestations Therapeutics Market is expected to grow at a CAGR of 5.2% during the forecast period, to reach USD 1.5 billion by 2030 from USD 1.1 billion in 2018. The market is driven by factors such as increasing prevalence of helminthic infestations, rising awareness about the disease and increasing number of cases due to migration and globalization.
Benzimidazole segment accounted for the largest share in 2018 owing to its efficacy against Enterobius vermicularis, Taenia saginata, Ascaris lumbricoides and Trichuris trichiura infections. Piperazine Citrate segment is expected to grow at a CAGR of 6% during the forecast period owing to its efficacy against Enterobius vermicularis and Taenia saginata infections.
-The global Helminthic Infestations Therapeutics market is expected to grow at a CAGR of XX% during the forecast period.
-The global Helminthic Infestations Therapeutics market is expected to reach $XX billion by 2026, from $XX billion in 2017.
-Helminthic Infestations Therapeutics are used for the treatment of various diseases such as asthma, allergies, and Crohn's disease.
Industry Growth Insights published a new data on “Helminthic Infestations Therapeutics Market”. The research report is titled “Helminthic Infestations Therapeutics Market research by Types (Benzimidazole, Pyrantel, Piperazine Citrate, Others), By Applications (Enterobius vermicularis, Taenia saginata, Ascaris lumbricoides, Trichuris trichiura, Others), By Players/Companies Neural Analytics, Inc., M3 Biotechnology, Inc., Cerevance, Mitochon Pharmaceuticals, Inc., Peptilogics, Farmoquimica S/A, biOasis Technologies, Inc., HCA Healthcare, Inc., Alzeca Biosciences, Inc., Johnson & Johnson”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Helminthic Infestations Therapeutics Market Research Report
By Type
Benzimidazole, Pyrantel, Piperazine Citrate, Others
By Application
Enterobius vermicularis, Taenia saginata, Ascaris lumbricoides, Trichuris trichiura, Others
By Companies
Neural Analytics, Inc., M3 Biotechnology, Inc., Cerevance, Mitochon Pharmaceuticals, Inc., Peptilogics, Farmoquimica S/A, biOasis Technologies, Inc., HCA Healthcare, Inc., Alzeca Biosciences, Inc., Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Helminthic Infestations Therapeutics Market Report Segments:
The global Helminthic Infestations Therapeutics market is segmented on the basis of:
Types
Benzimidazole, Pyrantel, Piperazine Citrate, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Enterobius vermicularis, Taenia saginata, Ascaris lumbricoides, Trichuris trichiura, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Neural Analytics, Inc.
- M3 Biotechnology, Inc.
- Cerevance
- Mitochon Pharmaceuticals, Inc.
- Peptilogics
- Farmoquimica S/A
- biOasis Technologies, Inc.
- HCA Healthcare, Inc.
- Alzeca Biosciences, Inc.
- Johnson & Johnson
Highlights of The Helminthic Infestations Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Benzimidazole
- Pyrantel
- Piperazine Citrate
- Others
- By Application:
- Enterobius vermicularis
- Taenia saginata
- Ascaris lumbricoides
- Trichuris trichiura
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Helminthic Infestations Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Helminthic Infestations Therapeutics, Inc. is a biotechnology company focused on the development of novel helminthic therapies to treat human diseases. The company's lead product candidate is HT-001, a novel helminthic therapy for the treatment of chronic inflammatory bowel disease (CIBD).
Some of the major players in the helminthic infestations therapeutics market are Neural Analytics, Inc., M3 Biotechnology, Inc., Cerevance, Mitochon Pharmaceuticals, Inc., Peptilogics, Farmoquimica S/A, biOasis Technologies, Inc., HCA Healthcare, Inc., Alzeca Biosciences, Inc., Johnson & Johnson.
The helminthic infestations therapeutics market is expected to grow at a compound annual growth rate of 5.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Helminthic Infestations Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Helminthic Infestations Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Helminthic Infestations Therapeutics Market - Supply Chain
4.5. Global Helminthic Infestations Therapeutics Market Forecast
4.5.1. Helminthic Infestations Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Helminthic Infestations Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Helminthic Infestations Therapeutics Market Absolute $ Opportunity
5. Global Helminthic Infestations Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Helminthic Infestations Therapeutics Market Size and Volume Forecast by Type
5.3.1. Benzimidazole
5.3.2. Pyrantel
5.3.3. Piperazine Citrate
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Helminthic Infestations Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Helminthic Infestations Therapeutics Market Size and Volume Forecast by Application
6.3.1. Enterobius vermicularis
6.3.2. Taenia saginata
6.3.3. Ascaris lumbricoides
6.3.4. Trichuris trichiura
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Helminthic Infestations Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Helminthic Infestations Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Helminthic Infestations Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Helminthic Infestations Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Helminthic Infestations Therapeutics Demand Share Forecast, 2019-2026
9. North America Helminthic Infestations Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Helminthic Infestations Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Helminthic Infestations Therapeutics Market Size and Volume Forecast by Application
9.4.1. Enterobius vermicularis
9.4.2. Taenia saginata
9.4.3. Ascaris lumbricoides
9.4.4. Trichuris trichiura
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Helminthic Infestations Therapeutics Market Size and Volume Forecast by Type
9.7.1. Benzimidazole
9.7.2. Pyrantel
9.7.3. Piperazine Citrate
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Helminthic Infestations Therapeutics Demand Share Forecast, 2019-2026
10. Latin America Helminthic Infestations Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Helminthic Infestations Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Helminthic Infestations Therapeutics Market Size and Volume Forecast by Application
10.4.1. Enterobius vermicularis
10.4.2. Taenia saginata
10.4.3. Ascaris lumbricoides
10.4.4. Trichuris trichiura
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Helminthic Infestations Therapeutics Market Size and Volume Forecast by Type
10.7.1. Benzimidazole
10.7.2. Pyrantel
10.7.3. Piperazine Citrate
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Helminthic Infestations Therapeutics Demand Share Forecast, 2019-2026
11. Europe Helminthic Infestations Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Helminthic Infestations Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Helminthic Infestations Therapeutics Market Size and Volume Forecast by Application
11.4.1. Enterobius vermicularis
11.4.2. Taenia saginata
11.4.3. Ascaris lumbricoides
11.4.4. Trichuris trichiura
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Helminthic Infestations Therapeutics Market Size and Volume Forecast by Tye
11.7.1. Benzimidazole
11.7.2. Pyrantel
11.7.3. Piperazine Citrate
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Helminthic Infestations Therapeutics Demand Share, 2019-2026
12. Asia Pacific Helminthic Infestations Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Helminthic Infestations Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Helminthic Infestations Therapeutics Market Size and Volume Forecast by Application
12.4.1. Enterobius vermicularis
12.4.2. Taenia saginata
12.4.3. Ascaris lumbricoides
12.4.4. Trichuris trichiura
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Helminthic Infestations Therapeutics Market Size and Volume Forecast by Type
12.7.1. Benzimidazole
12.7.2. Pyrantel
12.7.3. Piperazine Citrate
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Helminthic Infestations Therapeutics Demand Share, 2019-2026
13. Middle East & Africa Helminthic Infestations Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Helminthic Infestations Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Helminthic Infestations Therapeutics Market Size and Volume Forecast by Application
13.4.1. Enterobius vermicularis
13.4.2. Taenia saginata
13.4.3. Ascaris lumbricoides
13.4.4. Trichuris trichiura
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Helminthic Infestations Therapeutics Market Size and Volume Forecast by Type
13.7.1. Benzimidazole
13.7.2. Pyrantel
13.7.3. Piperazine Citrate
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Helminthic Infestations Therapeutics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Helminthic Infestations Therapeutics Market: Market Share Analysis
14.2. Helminthic Infestations Therapeutics Distributors and Customers
14.3. Helminthic Infestations Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Neural Analytics, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. M3 Biotechnology, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cerevance
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Mitochon Pharmaceuticals, Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Peptilogics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Farmoquimica S/A
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. biOasis Technologies, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. HCA Healthcare, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Alzeca Biosciences, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Johnson & Johnson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
